Search

for
Search:

Did you mean Prostate Volume?

GlossaryProstate Volume

measurement of the prostate gland's size in cubic centimeters

Prostate Volume, also known as Prostate Size or Prostatic Volume, refers to the measurement of the prostate gland's size, typically expressed in cubic centimeters (cc) or milliliters (mL). This measurement is important for diagnosing and managing conditions like benign prostatic hyperplasia (BPH) and prostate cancer. It is usually determined through imaging techniques such as ultrasound or MRI.

Related Terms

Sort by

Research

30 / 1000+ results

research DIHYDROTESTOSTERONE AND THE PROSTATE: THE SCIENTIFIC RATIONALE FOR 5α-REDUCTASE INHIBITORS IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA

235 citations , September 2004 in “The Journal of urology/The journal of urology”

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

research UP-02.011 Biofeedback Treatment for Dysfunctional Voiding Diagnosed in Adulthood

September 2011 in “Urology”

Biofeedback treatment for dysfunctional voiding in adults showed no symptom improvement.

research UP-02.009 Clinical Significance of Intravesical Prostatic Protrusion/Prostate Volume

September 2011 in “Urology”

The IPP index is linked to storage symptoms and leftover urine, and may help manage urinary tract symptoms.

Androgenic Alopecia as a Predictive Factor for Benign Prostatic Hyperplasia

research Alopecia androgénica como factor predictor de hiperplasia benigna de próstata

January 2018 in “Universidad Privada Antenor Orrego”

Male pattern baldness may be an early sign of noncancerous prostate enlargement.

The Association Between Male Pattern Baldness and Second to Fourth Finger Ratio with Prostate Cancer: A Prospective Cohort Study

research 1451 THE ASSOCIATION BETWEEN MALE PATTERN BALDNESS AND SECOND TO FORTH FINGER RATIO WITH PROSTATE CANCER- A PROSPECTIVE COHORT STUDY

April 2012 in “The Journal of Urology”

Male pattern baldness may predict prostate cancer risk.

research The Rationale for Inhibiting 5α-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer

108 citations , February 2008 in “The Journal of urology/The journal of urology”

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

research Prostate volume and its relationship with anthropometric variables among different ethnic groups of South-Kivu, DR Congo

6 citations , September 2020 in “African Journal of Urology”

Prostate size varies by ethnic group, age, residence, and blood glucose, but not by body measurements or fat.

research Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?

16 citations , April 2007 in “Journal of Obstetrics and Gynaecology Research”

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Effects of Finasteride Use on Prostate Volume and Serum PSA Levels in Young Patients

research Efeitos do uso da finasterida sobre o volume prostático e dosagem sérica do PSA em pacientes jovens

April 2017

Finasteride reduces prostate size and PSA levels in young patients.

Imaging Prostate Cancer With Technetium-99m Tricarbonyl Finasteride Dithiocarbamate

research Imaging prostate cancer (PCa) with [^99m Tc(CO)₃ ]finasteride dithiocarbamate

4 citations , March 2018 in “Journal of labelled compounds & radiopharmaceuticals”

A new compound was effective for imaging prostate cancer in rats.

research UP-02.010 Urinary PSA: Marker of Benign Prostatic Hyperplasia?

September 2011 in “Urology”

Urinary PSA could be an early marker for enlarged prostate.

research Androgenetic alopecia as an early marker of benign prostatic hyperplasia

28 citations , August 2011 in “Journal of The American Academy of Dermatology”

Early hair loss may indicate prostate issues.

research Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency

13 citations , January 2019 in “Endocrine journal”

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

research Re: Androgenetic Alopecia as an Early Marker of Benign Prostatic Hyperplasia

5 citations , September 2012 in “The Journal of Urology”

Early hair loss may indicate future prostate issues.

research Incidence of serious infectious events with methotrexate treatment: Metaanalysis of randomized controlled trials

February 2010 in “Journal of The American Academy of Dermatology”

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

research Finasteride

125 citations , January 1999 in “Drugs”

Finasteride effectively treats baldness but may cause sexual side effects.

research CHRONIC TREATMENT WITH FINASTERIDE DAILY DOES NOT AFFECT SPERMATOGENESIS OR SEMEN PRODUCTION IN YOUNG MEN

104 citations , October 1999 in “The Journal of Urology”

Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.

research Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis

19 citations , October 2018 in “PLOS ONE”

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Dutasteride, A Novel Dual 5-Alpha Reductase Inhibitor, Reduces Serum DHT to a Greater Extent Versus Finasteride and Achieves Maximal Reduction in a Larger Proportion of Patients

research Dutasteride, a novel dual 5-A reductase inhibitor, reduces serum DHT to a greater extent versus finasteride and achieves finasteride maximal reduction in a larger proportion of patients

12 citations , February 2003 in “European Urology Supplements”

Dutasteride reduces DHT more effectively than finasteride.

research Gleason grading controversies: what the chemoprevention trials have taught us

4 citations , May 2013 in “Canadian Urological Association Journal”

Finasteride reduces prostate cancer risk by 30% without affecting Gleason scores.

Impact of Finasteride on Serum PSA Levels in Men With Benign Prostatic Hyperplasia: A Systematic Review

research Impact of Finasteride on Serum PSA Levels in Men With BPH: A Systematic Review

October 2025 in “International Journal of Social health”

Finasteride lowers PSA levels and prostate size, requiring adjusted PSA interpretation for accurate cancer screening.

research The role of dutasteride in the treatment of benign prostatic obstruction and related conditions

October 2006 in “Aging Health”

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

research In-vivo uptake and metabolism of testosterone by the skin and other tissues of the rat

8 citations , May 1982 in “Journal of Endocrinology/Journal of endocrinology”

Rat skin takes up and processes testosterone differently than other organs, with testosterone being more important for the skin than its metabolite 5α-DHT.

research Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated Flutamide using LC-MS and GC-MS Spectrometry

1 citations , January 2021 in “Open Access Journal of Cancer & Oncology”

Energy healing treatment improved flutamide's solubility and stability, potentially enhancing its effectiveness for prostate cancer.

research Design, Synthesis, and Preclinical Evaluation of Prostate-Specific Membrane Antigen Targeted ^99mTc-Radioimaging Agents

148 citations , April 2009 in “Molecular Pharmaceutics”

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Search

for
Search:

Related Terms

Research

research DIHYDROTESTOSTERONE AND THE PROSTATE: THE SCIENTIFIC RATIONALE FOR 5α-REDUCTASE INHIBITORS IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA

research UP-02.011 Biofeedback Treatment for Dysfunctional Voiding Diagnosed in Adulthood

research UP-02.009 Clinical Significance of Intravesical Prostatic Protrusion/Prostate Volume

research Alopecia androgénica como factor predictor de hiperplasia benigna de próstata

research 1451 THE ASSOCIATION BETWEEN MALE PATTERN BALDNESS AND SECOND TO FORTH FINGER RATIO WITH PROSTATE CANCER- A PROSPECTIVE COHORT STUDY

research The Rationale for Inhibiting 5α-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer

research Prostate volume and its relationship with anthropometric variables among different ethnic groups of South-Kivu, DR Congo

research Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?

research Efeitos do uso da finasterida sobre o volume prostático e dosagem sérica do PSA em pacientes jovens

research Imaging prostate cancer (PCa) with [^99m Tc(CO)₃ ]finasteride dithiocarbamate

research UP-02.010 Urinary PSA: Marker of Benign Prostatic Hyperplasia?

research Androgenetic alopecia as an early marker of benign prostatic hyperplasia

research Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency

research Re: Androgenetic Alopecia as an Early Marker of Benign Prostatic Hyperplasia

research Incidence of serious infectious events with methotrexate treatment: Metaanalysis of randomized controlled trials

research Finasteride

research CHRONIC TREATMENT WITH FINASTERIDE DAILY DOES NOT AFFECT SPERMATOGENESIS OR SEMEN PRODUCTION IN YOUNG MEN

research Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis

research Dutasteride, a novel dual 5-A reductase inhibitor, reduces serum DHT to a greater extent versus finasteride and achieves finasteride maximal reduction in a larger proportion of patients

research Gleason grading controversies: what the chemoprevention trials have taught us

research Impact of Finasteride on Serum PSA Levels in Men With BPH: A Systematic Review

research The role of dutasteride in the treatment of benign prostatic obstruction and related conditions

research In-vivo uptake and metabolism of testosterone by the skin and other tissues of the rat

research Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated Flutamide using LC-MS and GC-MS Spectrometry

research Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?–Reply–I

research Disorders in Male Sexual Differentiation Due to 5α-Reductase-2 Deficiency

research Scientific Evaluation of A Unani Pharmacopoeia-Based Formulation on BPH in Animal Model

research Male pattern baldness and the risk of prostate cancer

research Dutasteride: A Review of its Use in the Management of Prostate Disorders

research Design, Synthesis, and Preclinical Evaluation of Prostate-Specific Membrane Antigen Targeted ^99mTc-Radioimaging Agents